In July 2023’s issue of McDermott’s Healthcare Regulatory Check-Up, significant regulatory activity is highlighted. Specifically, there are several recounted instances of criminal and civil enforcement actions falling under the purview of the False Claims Act (FCA) and the Anti-Kickback Statute (AKS).
The FCA is a federal law that imposes liability on persons or companies who defraud governmental programs. It is the federal government’s primary tool in combating fraud against the government. On the other hand, the AKS is a criminal statute that forbids the exchange (or offer to exchange), of anything valuable, in an effort to induce (or reward) the referral of federal health care program business.
In addition to the above, the newsletter reviews a handful of substantial reimbursement regulatory updates. These updates contribute to a rapidly transforming landscape, providing both challenges and opportunities for legal professionals navigating the healthcare sector.
Furthermore, a recent advisory opinion issued by the Office of the Inspector General (OIG) is looked into. The OIG’s perspective offers valuable insight into the thought processes and considerations of the office when addressing complex legal matters.
For more detailed information and to explore the topics further, professionals in the healthcare regulatory space are encouraged to read the full newsletter. By staying abreast of the latest developments, legal experts can readily adapt their practices to conform to evolving legal requirements and better serve their clients.